King's College London

• The complement receptor 3 (CD11b/CD18) agonist Leukadherin-1 suppresses human innate inflammatory signalling

  Roberts, A. L., Fürnrohr, B. G., Vyse, T. J. & Rhodes, B., 1 Sep 2016, In : Clinical and Experimental Immunology. 185, 3, p. 361-371 11 p.

  Research output: Contribution to journal › Article

• Reduced fluorescence versus forward scatter time-of-flight and increased peak versus integral fluorescence ratios indicate receptor clustering in flow cytometry

  Fürnrohr, B. G., Stein, M., Rhodes, B., Chana, P. S., Schett, G., Vyse, T. J., Herrmann, M. & Mielenz, D., 1 Jul 2015, In : Journal of Immunology. 195, 1, p. 377-385 9 p.

  Research output: Contribution to journal › Article

• Resequencing the susceptibility gene, ITGAM, identifies two functionally deleterious rare variants in systemic lupus erythematosus cases

  Roberts, A. L., Thomas, E., Bhosle, S., Game, L., Obraztsova, O., Aitman, T. J., Vyse, T. J. & Rhodes, B., 21 May 2014, In : Arthritis Research and Therapy. 16, 3, 11 p., R114.

  Research output: Contribution to journal › Article

• Systemic Lupus Erythematosus

  Rhodes, B. & Vyse, T. J., 29 Aug 2013, Genomic and Personalized Medicine. Ginsburg, G. S. & Willard, H. F. (eds.). 2 ed. Amsterdam: ELSEVIER ACADEMIC PRESS INC, Vol. 1-2. p. 970-982 13 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

View all (28) »